# Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

> **NCT07515079** · PHASE3 · RECRUITING · sponsor: **Bio-Thera Solutions** · enrollment: 406 (estimated)

## Conditions studied

- Diabetic Macular Edema (DME)

## Interventions

- **DRUG:** BAT5906 injection
- **DRUG:** Lucentis

## Key facts

- **NCT ID:** NCT07515079
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-09
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 406 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07515079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07515079, "Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07515079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*